04 Aug 2020 Other
Our life-saving work must continue
During this unprecedented time which is affecting every aspect of our lives, we strive to continue funding ground-breaking research and care for those affected by leukaemia and other blood cancers.
Leukaemia and other blood cancers don’t stop for COVID-19. Families affected are not only having to worry about blood cancer but now COVID-19 too. Our vital research to find better treatments and care must continue, and your support makes this possible.
In direct response to this crisis, to support those in most need we have just opened our 2020 Helping Hand Fund designed to ease financial concerns for those living with a blood cancer during the pandemic.
Our research
We are pleased to report that most of our research projects continue and we look forward to funding new potentially life-saving projects through our prestigious 2020 John Goldman Fellowships. Find out more about our ground-breaking research and care projects.
We are also delighted to announce that as part of our IMPACT Clinical Trials Partnership, we are now working with Great Ormond Street Hospital to study patients who have had a stem cell transplant in the past and have severe COVID-19. This study will see how these individuals respond to treatment and how this can be improved for this very vulnerable group.
Some of our clinical researchers and nurses have been redeployed to focus on COVID-19 related work we are happy to be able to support this essential effort.
How you can help us make a difference
COVID-19 is having a significant impact on charities across the UK, including us. The outbreak has unfortunately already affected many of our key fundraising events and activities. But our vital research and care must continue, so we have created a range of home-based fundraising events and activities for those wishing to get involved.
You can also support our cause by donating. We are truly grateful to all our brilliant supporters.
We proud that we are able to continue making a difference during these difficult times and we are grateful to our supporters for enabling us to make this difference. Thank you.
Related posts
15 February 2024
Parents join Leukaemia UK in calling for more donations to fund research to stop blood cancer ‘destroying childhoods’
Parents of children whose lives have been devastated by leukaemia have joined Leukaemia UK on International Childhood Cancer Day (February 15th) in calling for more research into the blood cancer. …
24 August 2022
Non-existent awareness of leukaemia symptoms “extremely worrying” – say leading UK leukaemia charities, as they launch memorable new campaign to get people “parroting on” about the symptoms
People over 55 also underestimate their risk, thinking that leukaemia is a childhood disease. Only 11% of over 55s thought that they had the greatest risk of leukaemia[1], whereas in…
13 November 2023
This year’s Olive Boles Innovation Award winner announced
Dr Kevin Rattigan, University of Glasgow, has been selected as this year’s Olive Boles Innovation Award winner – an accolade given to one Leukaemia UK John Goldman Fellow each year….
25 November 2025
Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl
Today, NICE announced its recommendation for Aucatzyl (obecabtagene autoleucel), a CAR-T therapy, to be made available on the NHS for treating adults aged 26 and over with relapsed or refractory…